Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJMBR (2) Autor Nardi,A.E. (2) Sardinha,A. (2) Amrein,R. (1) Araújo,C.G.S. (1) Crippa,J.A. (1) Dias,G.P. (1) Freire,R.C. (1) Hallak,J.E. (1) King,A.L. (1) Levitan,M.N. (1) Mezzasalma,M.A. (1) Mochcovitch,M.D. (1) Nascimento,I. (1) Soares-Filho,G.L. (1) Valença,A.M. (1) Veras,A.B. (1) Versiani,M. (1) da Costa,R.T. (1) de Carvalho,M.R. (1) de Cerqueira,A.C. (1) Mais... Palavra-chave Cardiac rehabilitation (1) Cardiovascular disease (1) Clonazepam (1) Depression (1) Efficacy (1) Exercise training (1) Mental health (1) Panic disorder (1) Paroxetine (1) Safety (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 2012 (1) 2011 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última Psychiatric disorders and cardiac anxiety in exercising and sedentary coronary artery disease patients: a case-control study BJMBR Sardinha,A.; Araújo,C.G.S.; Nardi,A.E.. Regular physical exercise has been shown to favorably influence mood and anxiety; however, there are few studies regarding psychiatric aspects of physically active patients with coronary artery disease (CAD). The objective of the present study was to compare the prevalence of psychiatric disorders and cardiac anxiety in sedentary and exercising CAD patients. A total sample of 119 CAD patients (74 men) were enrolled in a case-control study. The subjects were interviewed to identify psychiatric disorders and responded to the Cardiac Anxiety Questionnaire. In the exercise group (N = 60), there was a lower prevalence (45 vs 81%; P < 0.001) of at least one psychiatric diagnosis, as well as multiple comorbidities, when compared to the sedentary group (N =... Tipo: Info:eu-repo/semantics/article Palavras-chave: Exercise training; Mental health; Depression; Cardiovascular disease; Cardiac rehabilitation. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2012001200031 Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine BJMBR Nardi,A.E.; Valença,A.M.; Freire,R.C.; Mochcovitch,M.D.; Amrein,R.; Sardinha,A.; Levitan,M.N.; Nascimento,I.; de-Melo-Neto,V.L.; King,A.L.; de O. e Silva,A.C.; Veras,A.B.; Dias,G.P.; Soares-Filho,G.L.; da Costa,R.T.; Mezzasalma,M.A.; de Carvalho,M.R.; de Cerqueira,A.C.; Hallak,J.E.; Crippa,J.A.; Versiani,M.. The objective of the present randomized, open-label, naturalistic 8-week study was to compare the efficacy and safety of treatment with clonazepam (N = 63) and paroxetine (N = 57) in patients with panic disorder with or without agoraphobia. Efficacy assessment included number of panic attacks and clinician ratings of the global severity of panic disorders with the clinical global impression (CGI) improvement (CGI-I) and CGI severity (CGI-S) scales. Most patients were females (69.8 and 68.4% in the clonazepam and paroxetine groups, respectively) and age (mean ± SD) was 35.9 ± 9.6 years for the clonazepam group and 33.7 ± 8.8 years for the paroxetine group. Treatment with clonazepam versus paroxetine resulted in fewer weekly panic attacks at week 4 (0.1 vs... Tipo: Info:eu-repo/semantics/article Palavras-chave: Paroxetine; Clonazepam; Panic disorder; Efficacy; Safety. Ano: 2011 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2011000400015 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco